Literature DB >> 23501109

Synthesis and antibacterial evaluation of novel pleuromutilin derivatives.

Ruofeng Shang1, Yu Liu, Zhijun Xin, Wenzhu Guo, Zhiting Guo, Baocheng Hao, Liang Jianping.   

Abstract

A series of novel pleuromutilin derivatives possessing thioether moiety has been synthesized via acylation reaction under mild conditions. Their in vitro antibacterial activity against methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis, Escherichia coli, and Streptococcus agalactiae were tested by agar dilution method and Oxford cup assay. Among the 17 compounds screened, 14-O-[(4-methoxybenzamide-2- methylpropane-2-yl) thioacetate] mutilin 4i, 14-O-[(2-aminobenzamide-2-methylpropane-2-yl) thioacetate] mutilin 5a and 14-O-[(4-aminobenzamide-2-methylpropane-2-yl) thioacetate] mutilin 5c were resulted as most active antibacterial agents. Crown
Copyright © 2013. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23501109     DOI: 10.1016/j.ejmech.2013.01.048

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  A New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of Multidrug-Resistant Acinetobacter baumannii.

Authors:  Shajila Siricilla; Katsuhiko Mitachi; Junshu Yang; Shakiba Eslamimehr; Maddie R Lemieux; Bernd Meibohm; Yinduo Ji; Michio Kurosu
Journal:  J Med Chem       Date:  2017-03-22       Impact factor: 7.446

2.  Synthesis, biological activities and docking studies of pleuromutilin derivatives with piperazinyl urea linkage.

Authors:  Yuanyuan Zhang; Chuan Xie; Yang Liu; Feng Shang; Rushiya Shao; Jing Yu; Chunxia Wu; Xinghui Yao; Dongfang Liu; Zhouyu Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

3.  Chemical synthesis and biological activities of novel pleuromutilin derivatives with substituted amino moiety.

Authors:  Ruofeng Shang; Shengyu Wang; Ximing Xu; Yunpeng Yi; Wenzhu Guo; Jianping Liang
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.